Current landscape of mRNA technologies and delivery systems for new modality therapeutics

被引:14
作者
Lu, Ruei-Min [1 ]
Hsu, Hsiang-En [1 ]
Perez, Ser John Lynon P. [1 ]
Kumari, Monika [2 ]
Chen, Guan-Hong [1 ]
Hong, Ming-Hsiang [1 ]
Lin, Yin-Shiou [1 ]
Liu, Ching-Hang [1 ]
Ko, Shih-Han [1 ]
Concio, Christian Angelo P. [3 ]
Su, Yi-Jen [2 ]
Chang, Yi-Han [1 ]
Li, Wen-Shan [1 ,3 ]
Wu, Han-Chung [1 ,2 ]
机构
[1] Acad Sinica, Biomed Translat Res Ctr, Taipei 11571, Taiwan
[2] Acad Sinica, Inst Cellular & Organism Biol, 128 Acad Rd,Sect 2, Taipei 11529, Taiwan
[3] Acad Sinica, Inst Chem, 128 Acad Rd,Sect 2, Taipei 11529, Taiwan
关键词
mRNA Technology; mRNA therapeutics; Lipid nanoparticles; Targeting mRNA delivery systems; New modality therapeutics; CHIMERIC ANTIGEN RECEPTOR; LIPID NANOPARTICLES; IN-VIVO; PHOSPHODIESTER BONDS; GENE; PURIFICATION; CELLS; EXPRESSION; CANCER; PSEUDOURIDINE;
D O I
10.1186/s12929-024-01080-z
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Realizing the immense clinical potential of mRNA-based drugs will require continued development of methods to safely deliver the bioactive agents with high efficiency and without triggering side effects. In this regard, lipid nanoparticles have been successfully utilized to improve mRNA delivery and protect the cargo from extracellular degradation. Encapsulation in lipid nanoparticles was an essential factor in the successful clinical application of mRNA vaccines, which conclusively demonstrated the technology's potential to yield approved medicines. In this review, we begin by describing current advances in mRNA modifications, design of novel lipids and development of lipid nanoparticle components for mRNA-based drugs. Then, we summarize key points pertaining to preclinical and clinical development of mRNA therapeutics. Finally, we cover topics related to targeted delivery systems, including endosomal escape and targeting of immune cells, tumors and organs for use with mRNA vaccines and new treatment modalities for human diseases.
引用
收藏
页数:36
相关论文
共 267 条
[1]   Freeze-drying of nanoparticles: Formulation, process and storage considerations [J].
Abdelwahed, Wassim ;
Degobert, Ghania ;
Stainmesse, Serge ;
Fessi, Hatem .
ADVANCED DRUG DELIVERY REVIEWS, 2006, 58 (15) :1688-1713
[2]   Lyophilized mRNA-lipid nanoparticle vaccines with long-term stability and high antigenicity against SARS-CoV-2 [J].
Ai, Liangxia ;
Li, Yafei ;
Zhou, Li ;
Yao, Wenrong ;
Zhang, Hao ;
Hu, Zhaoyu ;
Han, Jinyu ;
Wang, Weijie ;
Wu, Junmiao ;
Xu, Pan ;
Wang, Ruiyue ;
Li, Zhangyi ;
Li, Zhouwang ;
Wei, Chengliang ;
Liang, Jianqun ;
Chen, Haobo ;
Yang, Zhimiao ;
Guo, Ming ;
Huang, Zhixiang ;
Wang, Xin ;
Zhang, Zhen ;
Xiang, Wenjie ;
Sun, Dazheng ;
Xu, Lianqiang ;
Huang, Meiyan ;
Lv, Bin ;
Peng, Peiqi ;
Zhang, Shangfeng ;
Ji, Xuhao ;
Luo, Huiyi ;
Chen, Nanping ;
Chen, Jianping ;
Lan, Ke ;
Hu, Yong .
CELL DISCOVERY, 2023, 9 (01)
[3]   Targeted Delivery of RNAi Therapeutics With Endogenous and Exogenous Ligand-Based Mechanisms [J].
Akinc, Akin ;
Querbes, William ;
De, Soma ;
Qin, June ;
Frank-Kamenetsky, Maria ;
Jayaprakash, K. Narayanannair ;
Jayaraman, Muthusamy ;
Rajeev, Kallanthottathil G. ;
Cantley, William L. ;
Dorkin, J. Robert ;
Butler, James S. ;
Qin, LiuLiang ;
Racie, Timothy ;
Sprague, Andrew ;
Fava, Eugenio ;
Zeigerer, Anja ;
Hope, Michael J. ;
Zerial, Marino ;
Sah, Dinah W. Y. ;
Fitzgerald, Kevin ;
Tracy, Mark A. ;
Manoharan, Muthiah ;
Koteliansky, Victor ;
de Fougerolles, Antonin ;
Maier, Martin A. .
MOLECULAR THERAPY, 2010, 18 (07) :1357-1364
[4]   Optimization of phospholipid chemistry for improved lipid nanoparticle (LNP) delivery of messenger RNA (mRNA) [J].
Alvarez-Benedicto, Ester ;
Farbiak, Lukas ;
Ramirez, Martha Marquez ;
Wang, Xu ;
Johnson, Lindsay T. ;
Mian, Osamah ;
Guerrero, Erick D. ;
Siegwart, Daniel J. .
BIOMATERIALS SCIENCE, 2022, 10 (02) :549-559
[5]   N1-methylpseudouridine-incorporated mRNA outperforms pseudouridine-incorporated mRNA by providing enhanced protein expression and reduced immunogenicity in mammalian cell lines and mice [J].
Andries, Oliwia ;
Mc Cafferty, Sean ;
De Smedt, Stefaan C. ;
Weiss, Ron ;
Sanders, Niek N. ;
Kitada, Tasuku .
JOURNAL OF CONTROLLED RELEASE, 2015, 217 :337-344
[6]   An overview of active and passive targeting strategies to improve the nanocarriers efficiency to tumour sites [J].
Attia, Mohamed F. ;
Anton, Nicolas ;
Wallyn, Justine ;
Omran, Ziad ;
Vandamme, Thierry F. .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2019, 71 (08) :1185-1198
[7]   Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine [J].
Baden, Lindsey R. ;
El Sahly, Hana M. ;
Essink, Brandon ;
Kotloff, Karen ;
Frey, Sharon ;
Novak, Rick ;
Diemert, David ;
Spector, Stephen A. ;
Rouphael, Nadine ;
Creech, C. Buddy ;
McGettigan, John ;
Khetan, Shishir ;
Segall, Nathan ;
Solis, Joel ;
Brosz, Adam ;
Fierro, Carlos ;
Schwartz, Howard ;
Neuzil, Kathleen ;
Corey, Larry ;
Gilbert, Peter ;
Janes, Holly ;
Follmann, Dean ;
Marovich, Mary ;
Mascola, John ;
Polakowski, Laura ;
Ledgerwood, Julie ;
Graham, Barney S. ;
Bennett, Hamilton ;
Pajon, Rolando ;
Knightly, Conor ;
Leav, Brett ;
Deng, Weiping ;
Zhou, Honghong ;
Han, Shu ;
Ivarsson, Melanie ;
Miller, Jacqueline ;
Zaks, Tal .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (05) :403-416
[8]   Research progress on circular RNA vaccines [J].
Bai, Yu ;
Liu, Dong ;
He, Qian ;
Liu, Jianyang ;
Mao, Qunying ;
Liang, Zhenglun .
FRONTIERS IN IMMUNOLOGY, 2023, 13
[9]   A Facile Method for the Removal of dsRNA Contaminant from In Vitro-Transcribed mRNA [J].
Baiersdoerfer, Markus ;
Boros, Gabor ;
Muramatsu, Hiromi ;
Mahiny, Azita ;
Vlatkovic, Irena ;
Sahin, Ugur ;
Kariko, Katalin .
MOLECULAR THERAPY-NUCLEIC ACIDS, 2019, 15 :26-35
[10]   The clinical progress of mRNA vaccines and immunotherapies [J].
Barbier, Ann J. ;
Jiang, Allen Yujie ;
Zhang, Peng ;
Wooster, Richard ;
Anderson, Daniel G. .
NATURE BIOTECHNOLOGY, 2022, 40 (06) :840-854